A leukemia therapy that Novartis (NVS) bought from the University of Pennsylvania has freed nine...

|About: Novartis AG (NVS)|By:, SA News Editor

A leukemia therapy that Novartis (NVS) bought from the University of Pennsylvania has freed nine out of 12 patients of the blood cancer. The treatment works by taking the sufferers' immune cells, reprogramming them to target leukemia cells, and then re-injecting them into the patients. Novartis will call the treatment CTL019.